Deprenyl Animal Health Inc. regulatory update

DAHI filed for Canadian marketing approval of Anipryl (I-selegiline) to treat cognitive dysfunction, an Alzheimer's-like disease in geriatric dogs. Anipryl is marketed in Canada by Draxis Health Inc....